Intrinsic Value of S&P & Nasdaq Contact Us

Assertio Holdings, Inc. ASRT NASDAQ

NASDAQ Capital Marke • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
31/100
0/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$2.38
-86.8%

Assertio Holdings, Inc. (ASRT) generated $-28.18M in operating cash flow for fiscal year 2025. After capital expenditures of $0.00, free cash flow was $-28.18M.

Free cash flow margin was -23.7% of revenue. Cash conversion ratio was 0.93x, suggesting some earnings are non-cash.

Criteria supported by this page:

  • HEALTH (67/100, Partial) — cash generation is adequate but may not fully cover debt in stressed conditions
  • MOAT (43/100, Fail) — limited free cash flow weakens the competitive position
  • INCOME (10/100) — Cash conversion ratio was 0.93x suggests some earnings are non-cash items

Overall SharesGrow Score: 31/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score
31/100
SG Score
View full scorecard →
~
VALUE
43/100
Price-to-Earnings & upside
→ Valuation
FUTURE
16/100
Analyst consensus
→ Forecast
PAST
25/100
→ Income
~
HEALTH
67/100
Debt-to-Equity & liquidity
Proven by this page
MOAT
43/100
Proven by this page
GROWTH
15/100
→ Income
INCOME
10/100
→ Income
Assertio Holdings, Inc. Cash Flow History
Metric TTM FY2025 FY2024 FY2023 FY2022
Operating Cash Flow $-28.18M$-28.18M$26.41M$49.6M$78.6M
Capital Expenditure $0.00$0.00$0.00$-628K$-274K
Free Cash Flow $-28.18M$-28.18M$26.41M$48.98M$78.32M
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message